These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 27882998)
21. Dopaminergic signaling of uncertainty and the aetiology of gambling addiction. Zack M; St George R; Clark L Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109853. PubMed ID: 31870708 [TBL] [Abstract][Full Text] [Related]
22. Disordered gambling: the evolving concept of behavioral addiction. Clark L Ann N Y Acad Sci; 2014 Oct; 1327(1):46-61. PubMed ID: 25336388 [TBL] [Abstract][Full Text] [Related]
23. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system. Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240 [TBL] [Abstract][Full Text] [Related]
24. Regional brain [(11)C]carfentanil binding following tobacco smoking. Domino EF; Hirasawa-Fujita M; Ni L; Guthrie SK; Zubieta JK Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():100-104. PubMed ID: 25598501 [TBL] [Abstract][Full Text] [Related]
25. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Heinz A; Reimold M; Wrase J; Hermann D; Croissant B; Mundle G; Dohmen BM; Braus DF; Schumann G; Machulla HJ; Bares R; Mann K Arch Gen Psychiatry; 2005 Jan; 62(1):57-64. PubMed ID: 15630073 [TBL] [Abstract][Full Text] [Related]
26. Reduced mu opioid receptor availability in schizophrenia revealed with [ Ashok AH; Myers J; Reis Marques T; Rabiner EA; Howes OD Nat Commun; 2019 Oct; 10(1):4493. PubMed ID: 31582737 [TBL] [Abstract][Full Text] [Related]
27. Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder. Heal DJ; Hallam M; Prow M; Gosden J; Cheetham S; Choi YK; Tarazi F; Hutson P J Psychopharmacol; 2017 Jun; 31(6):770-783. PubMed ID: 28376679 [TBL] [Abstract][Full Text] [Related]
29. Striatal dopamine D₂/D₃ receptor binding in pathological gambling is correlated with mood-related impulsivity. Clark L; Stokes PR; Wu K; Michalczuk R; Benecke A; Watson BJ; Egerton A; Piccini P; Nutt DJ; Bowden-Jones H; Lingford-Hughes AR Neuroimage; 2012 Oct; 63(1):40-6. PubMed ID: 22776462 [TBL] [Abstract][Full Text] [Related]
30. Pain-related opioidergic and dopaminergic neurotransmission: Dual meta-Analyses of PET radioligand studies. Garcia Guerra S; Spadoni A; Mitchell J; Strigo IA Brain Res; 2023 Apr; 1805():148268. PubMed ID: 36754138 [TBL] [Abstract][Full Text] [Related]
31. Decreased cerebral opioid receptors availability related to hormonal and psychometric profile in restrictive-type anorexia nervosa. Galusca B; Traverse B; Costes N; Massoubre C; Le Bars D; Estour B; Germain N; Redouté J Psychoneuroendocrinology; 2020 Aug; 118():104711. PubMed ID: 32460196 [TBL] [Abstract][Full Text] [Related]
32. Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Linnet J; Møller A; Peterson E; Gjedde A; Doudet D Addiction; 2011 Feb; 106(2):383-90. PubMed ID: 20883460 [TBL] [Abstract][Full Text] [Related]
33. Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Joutsa J; Johansson J; Niemelä S; Ollikainen A; Hirvonen MM; Piepponen P; Arponen E; Alho H; Voon V; Rinne JO; Hietala J; Kaasinen V Neuroimage; 2012 May; 60(4):1992-9. PubMed ID: 22348881 [TBL] [Abstract][Full Text] [Related]
34. Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study. McGowan S; Lawrence AD; Sales T; Quested D; Grasby P Arch Gen Psychiatry; 2004 Feb; 61(2):134-42. PubMed ID: 14757589 [TBL] [Abstract][Full Text] [Related]
35. Nigrostriatal and Mesolimbic D Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278 [TBL] [Abstract][Full Text] [Related]
36. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260 [TBL] [Abstract][Full Text] [Related]
37. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis. Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425 [TBL] [Abstract][Full Text] [Related]
38. Serotonin 1B receptor imaging in pathological gambling. Potenza MN; Walderhaug E; Henry S; Gallezot JD; Planeta-Wilson B; Ropchan J; Neumeister A World J Biol Psychiatry; 2013 Mar; 14(2):139-45. PubMed ID: 21936763 [TBL] [Abstract][Full Text] [Related]
39. Potential Biological Markers and Treatment Implications for Binge Eating Disorder and Behavioral Addictions. Mestre-Bach G; Potenza MN Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839185 [TBL] [Abstract][Full Text] [Related]
40. The neurochemical substrates of habitual and goal-directed control. Voon V; Joutsa J; Majuri J; Baek K; Nord CL; Arponen E; Forsback S; Kaasinen V Transl Psychiatry; 2020 Mar; 10(1):84. PubMed ID: 32127520 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]